Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:06:23.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T02:09:45.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T01:56:34.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T02:41:30.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The study page now returns a 403 Forbidden error, replacing the usual study record content with an access-denied screen while preserving site chrome like the header and footer.
    Difference
    21%
    Check dated 2026-09-20T01:15:11.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision tag at the bottom updates from v3.6.5 to v3.6.6. This signals a platform version update rather than a change to study content.
    Difference
    0.0%
    Check dated 2026-08-29T21:58:04.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.